Examkin

Soru

Zorluk: Çok zorInterpreting Imaging Results

A 66-year-old woman is evaluated in the clinic following an incidental finding on an abdominal ultrasound, which was performed during a workup for asymptomatic microscopic hematuria. She currently has no abdominal pain, nausea, vomiting, steatorrhea, or weight loss. She has no history of acute or chronic pancreatitis, and she does not consume alcohol. Physical examination reveals a soft, non-tender abdomen with no palpable masses. Liver function tests, serum lipase, and basic metabolic panel are within normal limits.

To further characterize the ultrasound finding, a multiphasic contrast-enhanced MRI of the abdomen with magnetic resonance cholangiopancreatography (MRCP) is performed. The imaging reveals a 3.6-cm, well-demarcated, multilocular cystic lesion located in the head of the pancreas. The mass is composed of numerous clustered microcysts, the majority of which are less than 5 mm in diameter, creating a "honeycomb" appearance. A prominent central, stellate scar is noted, which demonstrates delayed enhancement following gadolinium administration. The main pancreatic duct measures 2.2 mm in diameter, and there is no visible communication between the cystic lesion and the pancreatic ductal system. No mural nodules, peripheral eggshell calcifications, or biliary ductal dilation are present.

Based on the interpretation of these imaging findings, which of the following is the most appropriate next step in the management of this patient?

  1. Clinical observation without further diagnostic testing or interventionCevap
  2. B
    Endoscopic ultrasound with fine-needle aspiration of the cystic fluid
  3. C
    Referral for elective pancreaticoduodenectomy
  4. D
    Endoscopic retrograde cholangiopancreatography with ductal evaluation
  5. E
    Serial measurement of serum CA 19-9 and CEA levels every 3 months

Cevap

Clinical observation without further diagnostic testing or intervention
The correct approach is clinical observation without further testing. The patient's MRI demonstrates a multilocular, microcystic lesion with a honeycomb appearance and a central stellate scar exhibiting delayed enhancement. Furthermore, the lesion does not communicate with the pancreatic duct. This specific constellation of radiologic findings is pathognomonic for a serous cystadenoma (SCA). SCAs are lined by glycogen-rich cuboidal epithelium and have virtually no malignant potential (malignant transformation rate is less than 1%). Because the patient is entirely asymptomatic and the imaging is definitive, no further invasive diagnostic procedures (such as endoscopic ultrasound) or surgical resections are indicated. Intervention is generally reserved only for SCAs that cause symptoms due to mass effect (e.g., gastric outlet or biliary obstruction), which is not the case for this patient.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation.
The patient is an asymptomatic 66-year-old woman with an incidentally discovered pancreatic cyst and normal laboratory values.
Establishing the presence or absence of symptoms (like jaundice or abdominal pain) is critical for determining if surgical intervention is needed regardless of the cyst type.
2
Interpret the specific MRI/MRCP findings.
The lesion is a multilocular mass with microcysts (<5 mm), a "honeycomb" appearance, a delayed-enhancing central stellate scar, and no communication with the main pancreatic duct.
Differentiation of pancreatic cysts relies heavily on precise morphologic features on cross-sectional imaging.
3
Correlate the imaging features with the corresponding pathology.
The combination of a microcystic honeycomb architecture and a central stellate scar is pathognomonic for a serous cystadenoma (SCA).
Other cysts have different features: Mucinous cystic neoplasms (MCNs) typically have macrocysts and peripheral calcifications, while intraductal papillary mucinous neoplasms (IPMNs) communicate with the pancreatic ductal system.
4
Determine the appropriate management for the diagnosed condition.
Because SCAs are almost universally benign with a malignant transformation rate of <1%, asymptomatic patients require only clinical observation.
Guidelines recommend against resection or invasive diagnostic testing (like EUS-FNA) for asymptomatic cysts that display classic pathognomonic features of an SCA on high-quality imaging.

Anahtar Kavram

Pancreatic serous cystadenomas are characterized on MRI by a microcystic 'honeycomb' appearance with a central stellate scar and lack of ductal communication; because they are benign, asymptomatic lesions require only clinical observation.
Tahmini Süre:2m 0s
Bu soruyu puanla

Konular

Interpreting Imaging Results

Bu konudan daha fazla soru